CD4 and lobular neoplasia: Our results suggest that the correlation of CD4+CD25+CD127low UCB-Tregs administration with decreases in known disease measures such as anti-dsDNA IgG Ab as well as the quantification of the end organ damage including albuminuria and its multimodal mechanism of action makes them ideal for the treatment of LN.